Medisense Inc

Abbott Laboratories to Buy MediSense: The purchase, for about $876 million, or $45 a share, is a first step in the drug maker's plan to find ways to revive revenue and profit growth. MediSense Inc., based in Waltham, Mass., is the world's fourth-largest maker of glucose self-testing systems for people with diabetes. Abbott Park, Ill.

Abbott Laboratories to Buy MediSense: The purchase, for about $876 million, or $45 a share, is a first step in the drug maker's plan to find ways to revive revenue and profit growth. MediSense Inc., based in Waltham, Mass., is the world's fourth-largest maker of glucose self-testing systems for people with diabetes. Abbott Park, Ill.

A retired lumberjack with nine children, 17 grandchildren and 25 great-grandchildren must know a thing or two about virility. So who can argue with Ibrahim Selimbasic when he says his gift is in a glass of water? Selimbasic is 88, toothless and a little unsteady on his feet, but he still has a mischievous twinkle in his eye, for which he thanks a mineral spring trickling down nearby Konjuh Mountain.

Within minutes after the end of the trading day on Nasdaq, a peculiar thing happens. Large trades--sometimes the biggest of the day for certain stocks--are suddenly reported on Nasdaq's "tape," the public running list of trades. They have an "s" next to them, indicating that they are being reported late. Nasdaq rules strictly require that trades be reported within 90 seconds after they've been executed.